Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Zahrieh

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Journal of Geriatric Oncology|September 20, 2020
Toxicity and survival outcomes in older adults receiving concurrent or sequential chemoradiation for stage III non-small cell lung cancer in Alliance trials (Alliance A151812)Ronald J Maggiore, David Zahrieh, Ryan P McMurray, et al.
Blood|May 10, 2003
Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantationMartha Wadleigh, Paul G Richardson, David Zahrieh, et al.
Blood|May 13, 2004
Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trialStephanie J Lee, David Zahrieh, Edward Agura, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 8, 2020
Real-world experiences with acupuncture among breast cancer survivors: a cross-sectional survey studyJacqueline Zayas, Kathryn J Ruddy, Janet E Olson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2006
Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIIIJürg Bernhard, David Zahrieh, Monica Castiglione-Gertsch, et al.
Seminars in Oncology|January 24, 2023
Dexamethasone to prevent everolimus-induced stomatitis (Alliance MIST Trial: A221701)Kathryn J Ruddy, David Zahrieh, Jun He, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatmentMarco Colleoni, Giuseppe Viale, David Zahrieh, et al.
Cancers|May 27, 2026
Placebo Response in Phase II-III Symptom Intervention Studies: A Focus on Chemotherapy-Induced Peripheral Neuropathy and Associated Neuropathic PainDavid Zahrieh, Daniel Satele, Hiboombe Haamankuli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2005
Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93, Carl-Magnus Rudenstam, David Zahrieh, et al.
Blood|April 29, 2004
Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantationVincent T Ho, David Zahrieh, Ephraim Hochberg, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Journal of Geriatric Oncology|September 20, 2020
Toxicity and survival outcomes in older adults receiving concurrent or sequential chemoradiation for stage III non-small cell lung cancer in Alliance trials (Alliance A151812)Ronald J Maggiore, David Zahrieh, Ryan P McMurray, et al.
Blood|May 10, 2003
Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantationMartha Wadleigh, Paul G Richardson, David Zahrieh, et al.
Blood|May 13, 2004
Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trialStephanie J Lee, David Zahrieh, Edward Agura, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 8, 2020
Real-world experiences with acupuncture among breast cancer survivors: a cross-sectional survey studyJacqueline Zayas, Kathryn J Ruddy, Janet E Olson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2006
Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIIIJürg Bernhard, David Zahrieh, Monica Castiglione-Gertsch, et al.
Seminars in Oncology|January 24, 2023
Dexamethasone to prevent everolimus-induced stomatitis (Alliance MIST Trial: A221701)Kathryn J Ruddy, David Zahrieh, Jun He, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatmentMarco Colleoni, Giuseppe Viale, David Zahrieh, et al.
Cancers|May 27, 2026
Placebo Response in Phase II-III Symptom Intervention Studies: A Focus on Chemotherapy-Induced Peripheral Neuropathy and Associated Neuropathic PainDavid Zahrieh, Daniel Satele, Hiboombe Haamankuli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2005
Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93, Carl-Magnus Rudenstam, David Zahrieh, et al.
Blood|April 29, 2004
Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantationVincent T Ho, David Zahrieh, Ephraim Hochberg, et al.
Pageof 9